Drawing for LOSOKI KIDS

USPTO serial 98238965

LOSOKI KIDS

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
Law office
NEW APPLICATION PROCESSING

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LOSOKI KIDS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

xionghui murong

12900 Oxon RoadHerndon, VA 20171UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Albumin dietary supplements; Amino acids for medical purposes; Casein dietary supplements; Collagen for medical purposes; Dietary fiber to aid digestion; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Food for babies; Lecithin dietary supplements; Medical dressings; Medicated toothpaste; Medicinal drinks; Mineral dietary supplements; Mouthwashes for medical purposes; Protein dietary supplements; Protein supplements; Protein supplements for animals; Vitamin supplements; Yeast dietary supplementsACTIVESep 20, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 8, 2023MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Nov 8, 2023MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Nov 8, 2023ABN1ABANDONMENT - EXPRESS MAILED
Nov 6, 2023EXARTEAS EXPRESS ABANDONMENT RECEIVED
Oct 29, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2023NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance